SYK and retinoblastoma: We aimed to investigate whether: (1) SYK can be used as a specific target for RB; (2) cell immunotherapy is an effective and safe approach for RB treatment; and (3) presenting DCs with lentivirus could promote T-lymphocyte maturation and increase specific cytotoxicity against RB-Y79 cells in vitro.